Biosystems International Raises €3.5 Million
Biosystems International, a Paris-based developer of monoclonal antibodies for cancer treatment, has raised €3.5 million in new VC funding from SGAM AI, individual angels and an undisclosed European pharma company.
30 October 2008•2 mins read
